INVIR IO Trademark

Trademark Overview

On Thursday, November 16, 2017, a trademark application was filed for INVIR IO with the United States Patent and Trademark Office. The USPTO has given the INVIR IO trademark a serial number of 79226928. The federal status of this trademark filing is REGISTERED as of Tuesday, January 3, 2023. This trademark is owned by TRANSGENE SA. The INVIR IO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Therapeutic vaccines in oncology; immunotherapy products, namely, pharmaceutical products for the prevention and treatment of cancer, for use in oncology; Human therapeutic vaccine preparations for use in oncology; immunotherapy products in oncology for human use being anti-cancer preparations

Design and development of therapeutic vaccines and immunotherapy products in oncology
invir io

General Information

Serial Number79226928
Word MarkINVIR IO
Filing DateThursday, November 16, 2017
Status700 - REGISTERED
Status DateTuesday, January 3, 2023
Registration Number6937963
Registration DateTuesday, January 3, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements

Description of MarkThe mark consists of the wording "INVIR" in lowercase letters in the color blue and the wording "IO" in lowercase letters in the color white within an orange circle.
Goods and ServicesTherapeutic vaccines in oncology; immunotherapy products, namely, pharmaceutical products for the prevention and treatment of cancer, for use in oncology; Human therapeutic vaccine preparations for use in oncology; immunotherapy products in oncology for human use being anti-cancer preparations
Indication of Colors claimedThe color(s) blue, orange, and white is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"IO"
Goods and ServicesDesign and development of therapeutic vaccines and immunotherapy products in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 26, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 26, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTRANSGENE SA
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressFR
Party NameTRANSGENE SA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressFR
Party NameTRANSGENE SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Trademark Events

Event DateEvent Description
Tuesday, May 9, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, April 15, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 14, 2023FINAL DISPOSITION PROCESSED
Monday, April 3, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 3, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 3, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Monday, October 17, 2022NOTIFICATION PROCESSED BY IB
Wednesday, September 28, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 28, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, September 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 24, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 24, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 7, 2022NON-FINAL ACTION E-MAILED
Thursday, April 7, 2022NON-FINAL ACTION WRITTEN
Monday, November 22, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, May 21, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, February 27, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 19, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, February 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 19, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, May 13, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 11, 2020ASSIGNED TO LIE
Friday, October 25, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, August 2, 2019NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, July 17, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 17, 2019NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, April 24, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 23, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 23, 2018LETTER OF SUSPENSION E-MAILED
Tuesday, October 23, 2018SUSPENSION LETTER WRITTEN
Thursday, September 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 12, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 12, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 30, 2018REFUSAL PROCESSED BY IB
Monday, March 12, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 12, 2018REFUSAL PROCESSED BY MPU
Tuesday, March 6, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 5, 2018NON-FINAL ACTION WRITTEN
Friday, March 2, 2018APPLICATION FILING RECEIPT MAILED
Wednesday, February 28, 2018ASSIGNED TO EXAMINER
Monday, February 26, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 15, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

invir oncology products therapeutic immunotherapy human preparations cancer vaccines being development